The Indian health ministry has announced that certain drugs approved for use in...
New legislation gives patients equal access to cancer trials in Illinois
Illinois lawmakers have introduced new legislation called SB1711, the Clinical Trial Participation Act, that gives all cancer patients access to potentially life-saving breakthrough medical treatments in clinical trials.
China approves first anti-viral drug against coronavirus Covid-19
Anti-viral drug Favilavir has secured approval from the National Medical Products Administration of China to treat coronavirus Covid-19, according to media reports.
FDA accepts BLA from AstraZeneca and Daiichi for targeted chemotherapy
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has accepted their biologics license application (BLA) for targeted cytotoxic chemotherapy trastuzumab deruxtecan.
WHO introduces human genome editing global registry
The World Health Organisation has approved the first phase of a new global registry to record the research conducted on human genome editing.
FDA encourages drugmakers to enrol men in breast cancer trials
The US Food and Drug Administration (FDA) has released new draft guidance encouraging drugmakers to enrol male patients in breast cancer clinical trials.
Nestle-sponsored trial violates India’s Infant Milk Substitutes Act
A clinical trial sponsored by infant milk substitutes and infant foods maker Nestle has violated Indian law under the Infant Milk Substitutes (IMS) Act.
April’s top news stories
Chinese clinical-stage biopharmaceutical company I-Mab Biopharma and German biotech company MorphoSys have begun the first dosed Phase III clinical study to assess investigational human CD38 antibody TJ202/MOR202 in combination with lenalidomide in patients suffering from relapsed or refractory multiple myeloma; and A small clinical trial by researchers at the University of Edinburgh in the UK has showed that cilostazol and isosorbide mononitrate could prevent recurrence of stroke and vascular dementia. Drugdevelopment-technology.com wraps up the key headlines from April 2019.